IN2013MU01920A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01920A
IN2013MU01920A IN1920MU2013A IN2013MU01920A IN 2013MU01920 A IN2013MU01920 A IN 2013MU01920A IN 1920MU2013 A IN1920MU2013 A IN 1920MU2013A IN 2013MU01920 A IN2013MU01920 A IN 2013MU01920A
Authority
IN
India
Prior art keywords
disclosed
conditions
thiazolyl
obesity
cancers
Prior art date
Application number
Other languages
English (en)
Inventor
Kunju Vasu Kamala
Suresh Thacker Pavitra
Anilkumar Sharma Jayesh
Abhiramasundari A
Original Assignee
Kamala K Vasu Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamala K Vasu Dr filed Critical Kamala K Vasu Dr
Priority to IN1920MU2013 priority Critical patent/IN2013MU01920A/en
Publication of IN2013MU01920A publication Critical patent/IN2013MU01920A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1920MU2013 2013-05-31 2013-05-31 IN2013MU01920A (cg-RX-API-DMAC7.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1920MU2013 IN2013MU01920A (cg-RX-API-DMAC7.html) 2013-05-31 2013-05-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1920MU2013 IN2013MU01920A (cg-RX-API-DMAC7.html) 2013-05-31 2013-05-31

Publications (1)

Publication Number Publication Date
IN2013MU01920A true IN2013MU01920A (cg-RX-API-DMAC7.html) 2015-09-25

Family

ID=54394961

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1920MU2013 IN2013MU01920A (cg-RX-API-DMAC7.html) 2013-05-31 2013-05-31

Country Status (1)

Country Link
IN (1) IN2013MU01920A (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
MX2022001105A (es) Anticuerpos anti tigit.
MX2016003129A (es) Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano.
GEP201706612B (en) Methods for the treatment of breast cancer
MX2016004678A (es) Composiciones para el tratamiento del cancer.
GB201310909D0 (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
MX2015015249A (es) Peptidos terapeuticos.
SG10201709090UA (en) Sobetirome in the treatment of myelination diseases
PH12015501071A1 (en) Combination therapy of anti-her3 antibodies
PT3065764T (pt) Análogo de minigastrina, em particular para uso no diagnóstico e/ou tratamento de tumor positivo ao recetor cck2
SMT202100180T1 (it) Anticorpi coniugati contro ly75 per il trattamento del cancro
MX365403B (es) Peptidos y metodos para usarlos.
EP2996721A4 (en) Methods and compositions for prognosis, diagnosis and treatment of adam8-expressing cancer
SG11201507354QA (en) Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
PH12015500169A1 (en) Prediction of treatment response to jak/stat inhibitor
MX2016015163A (es) Biomarcadores mit y metodos para su uso.
IN2015DN00515A (cg-RX-API-DMAC7.html)
EP3015864A4 (en) Biomarkers for the diagnosis and the response to treatment of pancreatic cancer
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
LT2984108T (lt) Anti-s100a7 antikūnai, skirti vėžio gydymui ir diagnozei
PL2943215T3 (pl) Peptydy pochodzące z laktoferycyny do zastosowania w leczeniu nowotworu
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
IS2934B (is) Mólýbden efnasambönd til notkunar við meðferð á sýaníðeitrun
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia